Toxin-producing Clostridium difficile strains as long-term gut colonizers in healthy infants

Ingegerd Adlerberth1, Haihui Huang, Erika Lindberg

  • 1Department of Infectious Diseases, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden.

Insights

Certain Clostridium difficile strains, particularly toxin-producing types 001 and 014, persist longer in infant guts. These strains may act as a reservoir for infections in adults.

Area of Science:

  • Microbiology
  • Gastroenterology
  • Pediatrics

Background:

  • Clostridium difficile colonizes the human gut, with toxin-producing strains causing disease under heavy burden.
  • Infants are frequently colonized but rarely develop C. difficile disease, with strain-specific colonization capacity unknown.

Purpose of the Study:

  • To investigate if Clostridium difficile strains differ in their capacity to colonize and persist in the infant gut microbiota.
  • To characterize toxin gene carriage and toxin production in C. difficile strains colonizing infants.

Main Methods:

  • PCR ribotyping of the 16S-23S rRNA intergenic spacer region was used to strain type C. difficile isolates from 42 infants.
  • Isolates were characterized for toxin genes (tcdA, tcdB, cdtA/B) and in vitro toxin B production.

Main Results:

  • Most C. difficile strains (71%) were toxin producers; 51% belonged to disease-associated adult ribotypes 001 or 014.
  • Ribotypes 001 and 014 showed significantly higher persistence (≥6 months) in the infant gut microbiota.
  • Ribotype 001 strains were acquired early, had higher counts in neonates, and were found in 13/15 infants with long-term colonizers.

Conclusions:

  • Toxin-producing C. difficile ribotypes 001 and 014 possess enhanced fitness in the infant gut microbiota.
  • Long-term colonization by toxin-producing strains in young children may serve as a reservoir for strains causing adult disease.

Related Concept Videos

Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
73
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid...
95
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
75
Bacterial Toxins01:12

Bacterial Toxins

Bacterial toxins are sophisticated virulence factors that enable pathogenic bacteria to interact with, invade, and damage host tissues. These toxins fall broadly into two types: protein exotoxins, which are secreted into the environment and target specific host receptors, and lipopolysaccharide endotoxins, which are structural components of the bacterial outer membrane released primarily during bacterial lysis or membrane shedding. Exotoxins generally act more selectively, binding to cell...
160
Introduction to the Human Microbiota01:22

Introduction to the Human Microbiota

Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity,...
226
Microbiota of the Stomach and Small Intestine01:27

Microbiota of the Stomach and Small Intestine

The human gastrointestinal (GI) tract is characterized by distinct physicochemical conditions that shape its microbial communities. Among these, the stomach presents a particularly challenging environment for microbial colonization due to its highly acidic pH, ranging from 1 to 3. This extreme acidity effectively limits microbial density. However, certain acid-tolerant microorganisms are capable of surviving in this niche. Notably, Helicobacter pylori can colonize the gastric mucosa,...
95